Literature DB >> 20164214

The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences.

M J Hannon1, C J Thompson.   

Abstract

Hyponatraemia is the commonest electrolyte abnormality found in hospital inpatients, and is associated with a greatly increased morbidity and mortality. The syndrome of inappropriate antidiuretic hormone (SIADH) is the most frequent cause of hyponatraemia in hospital inpatients. SIADH is the clinical and biochemical manifestation of a wide range of disease processes, and every case warrants investigation of the underlying cause. In this review, we will examine the prevalence, pathophysiology, clinical characteristics and clinical consequences of hyponatraemia due to SIADH.

Entities:  

Mesh:

Year:  2010        PMID: 20164214     DOI: 10.1530/EJE-09-1063

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  34 in total

1.  A case of the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with lupus erythematosus in the central nervous system.

Authors:  Hiroaki Hara; Hajime Hasegawa; Mizuki Iwanaga; Tomonya Ogawa; Akihiko Matsuda; Koichi Kanozawa; Hitoshi Kato; Tetsuya Mitarai
Journal:  CEN Case Rep       Date:  2012-08-15

2.  Primary sellar neuroblastoma presenting with syndrome of inappropriate secretion of anti-diuretic hormone.

Authors:  Bishan Radotra; Vasileios Apostolopoulos; Ann Sandison; Emma C I Hatfield; Nigel Mendoza; Jill Moss; Amrish Mehta; Mark Glaser; Karim Meeran; Federico Roncaroli
Journal:  Endocr Pathol       Date:  2010-12       Impact factor: 3.943

3.  Single-tubule RNA-Seq uncovers signaling mechanisms that defend against hyponatremia in SIADH.

Authors:  Jae Wook Lee; Mohammad Alsady; Chung-Lin Chou; Theun de Groot; Peter M T Deen; Mark A Knepper; Carolyn M Ecelbarger
Journal:  Kidney Int       Date:  2017-08-23       Impact factor: 10.612

4.  Possible anti-VGKC autoimmune limbic encephalitis associated with SIADH.

Authors:  Nicholas Black; Hazim Hamada
Journal:  BMJ Case Rep       Date:  2018-03-07

5.  Low-dose tolvaptan for the treatment of hyponatremia in the syndrome of inappropriate ADH secretion (SIADH).

Authors:  Birgit Harbeck; Ulrich Lindner; Christian S Haas
Journal:  Endocrine       Date:  2016-03-09       Impact factor: 3.633

Review 6.  The Efficacy and Safety of Tolvaptan in Patients with Hyponatremia: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Benlei Li; Dong Fang; Cheng Qian; Hongliang Feng; Yanggan Wang
Journal:  Clin Drug Investig       Date:  2017-04       Impact factor: 2.859

Review 7.  Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH).

Authors:  A Peri; N Pirozzi; G Parenti; F Festuccia; P Menè
Journal:  J Endocrinol Invest       Date:  2010-10-08       Impact factor: 4.256

8.  Efficacy and safety of two different tolvaptan doses in the treatment of hyponatremia in the Emergency Department.

Authors:  Luigi Mario Castello; Marco Baldrighi; Alice Panizza; Ettore Bartoli; Gian Carlo Avanzi
Journal:  Intern Emerg Med       Date:  2016-07-21       Impact factor: 3.397

Review 9.  Management of hyponatraemia in older people: old threats and new opportunities.

Authors:  Roy L Soiza; Hannah S C Talbot
Journal:  Ther Adv Drug Saf       Date:  2011-02

10.  Influenza A: another cause of SIADH?

Authors:  Simon Mifsud; Maria Alessandra Zammit; Ramon Casha; Claudia Fsadni
Journal:  BMJ Case Rep       Date:  2018-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.